What is Off-label use?
Off-label use is prescribing or administering an FDA-approved drug or device for an indication, dose, or population outside its approved labeling. It is legal and common when supported by clinical judgment, and aesthetic medicine relies on it heavily, which raises the documentation bar for consent language and clinical rationale.
How it works in an aesthetic clinic
Many familiar aesthetic treatments are off-label applications: a neurotoxin approved for specific areas used in others, or medications repurposed at different doses in wellness protocols. The clinic's obligations are disclosure and documentation: the consent names the off-label status where it is material, and the chart records the provider's rationale for the clinical decision.
Off-label use vs an unapproved product
| Off-label use | An FDA-approved product used beyond its label, under physician judgment |
|---|---|
| An unapproved product | A product that never went through FDA approval at all: a different risk category entirely |
Why it matters for clinic operators
Clinical use and marketing are different questions: providers may exercise off-label judgment, but advertising off-label claims invites FDA and FTC attention. Keep marketing claims on-label and conservative, and have counsel review treatment-menu language.
On the platform: Charting & consent
See Gracero run your clinic.
A 15-minute demo: booking, payments, memberships, and the aesthetic layer, all in one platform.
Book a demo